- Streamline Health Solutions, Inc. is a relatively unknown, high-growth investment opportunity in the medical billing space trading at a ~ $68 million market cap.
- Streamline’s acquisition of Avelead will double current sales immediately and create an opportunity for cross-selling solutions to hospitals.
- Streamline’s (together with Avelead) core business is a $900M recurring sales opportunity which implies 45x sales growth.
- Even though the COVID pandemic has been an obstacle for sales, the core business still grew 56% over the last 12 months.
For further details see:
Streamline Health Solutions, Inc. Is A Massive Medical SaaS Opportunity